188 related articles for article (PubMed ID: 35094360)
21. Expression levels of PEPT1 and ABCG2 play key roles in 5-aminolevulinic acid (ALA)-induced tumor-specific protoporphyrin IX (PpIX) accumulation in bladder cancer.
Hagiya Y; Fukuhara H; Matsumoto K; Endo Y; Nakajima M; Tanaka T; Okura I; Kurabayashi A; Furihata M; Inoue K; Shuin T; Ogura S
Photodiagnosis Photodyn Ther; 2013 Sep; 10(3):288-95. PubMed ID: 23993855
[TBL] [Abstract][Full Text] [Related]
22. Predictive biomarkers for 5-ALA-PDT can lead to personalized treatments and overcome tumor-specific resistances.
Mastrangelopoulou M; Grigalavicius M; Raabe TH; Skarpen E; Juzenas P; Peng Q; Berg K; Theodossiou TA
Cancer Rep (Hoboken); 2022 Dec; 5(12):e1278. PubMed ID: 32737955
[TBL] [Abstract][Full Text] [Related]
23. Kinetic Evaluation of Determinant Factors for Cellular Accumulation of Protoporphyrin IX Induced by External 5-Aminolevulinic Acid for Photodynamic Cancer Therapy.
Nakanishi T; Ogawa T; Yanagihara C; Tamai I
J Pharm Sci; 2015 Sep; 104(9):3092-100. PubMed ID: 25959076
[TBL] [Abstract][Full Text] [Related]
24. ABCG2 influence on the efficiency of photodynamic therapy in glioblastoma cells.
Müller P; Abdel Gaber SA; Zimmermann W; Wittig R; Stepp H
J Photochem Photobiol B; 2020 Sep; 210():111963. PubMed ID: 32795847
[TBL] [Abstract][Full Text] [Related]
25. Novel potential photodynamic therapy strategy using 5-Aminolevulinic acid for ovarian clear-cell carcinoma.
Teshigawara T; Mizuno M; Ishii T; Kitajima Y; Utsumi F; Sakata J; Kajiyama H; Shibata K; Ishizuka M; Kikkawa F
Photodiagnosis Photodyn Ther; 2018 Mar; 21():121-127. PubMed ID: 29196245
[TBL] [Abstract][Full Text] [Related]
26. ABCG2 transporter inhibitor restores the sensitivity of triple negative breast cancer cells to aminolevulinic acid-mediated photodynamic therapy.
Palasuberniam P; Yang X; Kraus D; Jones P; Myers KA; Chen B
Sci Rep; 2015 Aug; 5():13298. PubMed ID: 26282350
[TBL] [Abstract][Full Text] [Related]
27. Fractionated illumination in oesophageal ALA-PDT: effect on ferrochelatase activity.
van Den Boogert J; van Staveren HJ; de Bruin RWF ; de Rooij FWM ; Edixhoven-Bosdijk A; Siersema PD; van Hillegersberg R
J Photochem Photobiol B; 2000 Jun; 56(1):53-60. PubMed ID: 11073316
[TBL] [Abstract][Full Text] [Related]
28. 5-Aminolevulinic Acid as a Theranostic Agent for Tumor Fluorescence Imaging and Photodynamic Therapy.
Howley R; Chandratre S; Chen B
Bioengineering (Basel); 2023 Apr; 10(4):. PubMed ID: 37106683
[TBL] [Abstract][Full Text] [Related]
29. Identification and pharmacological modification of resistance mechanisms to protoporphyrin-mediated photodynamic therapy in human cutaneous squamous cell carcinoma cell lines.
Schary N; Novak B; Kämper L; Yousf A; Lübbert H
Photodiagnosis Photodyn Ther; 2022 Sep; 39():103004. PubMed ID: 35811052
[TBL] [Abstract][Full Text] [Related]
30. Mangostin enhances efficacy of aminolevulinic acid-photodynamic therapy against cancer through inhibition of ABCG2 activity.
Lai HW; Tani Y; Sukatta U; Rugthaworn P; Thepyos A; Yamamoto S; Fukuhara H; Inoue K; Yuasa H; Nakamura H; Ogura SI
Photodiagnosis Photodyn Ther; 2023 Dec; 44():103798. PubMed ID: 37696317
[TBL] [Abstract][Full Text] [Related]
31. Aminolevulinic Acid-Based Tumor Detection and Therapy: Molecular Mechanisms and Strategies for Enhancement.
Yang X; Palasuberniam P; Kraus D; Chen B
Int J Mol Sci; 2015 Oct; 16(10):25865-80. PubMed ID: 26516850
[TBL] [Abstract][Full Text] [Related]
32. Photodynamic therapy involves an antiangiogenic mechanism and is enhanced by ferrochelatase inhibitor in urothelial carcinoma.
Inoue K; Fukuhara H; Kurabayashi A; Furihata M; Tsuda M; Nagakawa K; Fujita H; Utsumi K; Shuin T
Cancer Sci; 2013 Jun; 104(6):765-72. PubMed ID: 23480042
[TBL] [Abstract][Full Text] [Related]
33. Experimental investigation of a combinational iron chelating protoporphyrin IX prodrug for fluorescence detection and photodynamic therapy.
Magnussen A; Reburn C; Perry A; Wood M; Curnow A
Lasers Med Sci; 2022 Mar; 37(2):1155-1166. PubMed ID: 34218351
[TBL] [Abstract][Full Text] [Related]
34. Cadherin 13 overexpression as an important factor related to the absence of tumor fluorescence in 5-aminolevulinic acid-guided resection of glioma.
Suzuki T; Wada S; Eguchi H; Adachi J; Mishima K; Matsutani M; Nishikawa R; Nishiyama M
J Neurosurg; 2013 Nov; 119(5):1331-9. PubMed ID: 24010971
[TBL] [Abstract][Full Text] [Related]
35. Mechanism of cell death by 5-aminolevulinic acid-based photodynamic action and its enhancement by ferrochelatase inhibitors in human histiocytic lymphoma cell line U937.
Amo T; Kawanishi N; Uchida M; Fujita H; Oyanagi E; Utsumi T; Ogino T; Inoue K; Shuin T; Utsumi K; Sasaki J
Cell Biochem Funct; 2009 Dec; 27(8):503-15. PubMed ID: 19735078
[TBL] [Abstract][Full Text] [Related]
36. Susceptibility to 5-aminolevulinic acid based photodynamic therapy in WHO I meningioma cells corresponds to ferrochelatase activity.
Hefti M; Holenstein F; Albert I; Looser H; Luginbuehl V
Photochem Photobiol; 2011; 87(1):235-41. PubMed ID: 21073472
[TBL] [Abstract][Full Text] [Related]
37. Accumulation of protoporphyrin-IX (PpIX) in leukemic cell lines following induction by 5-aminolevulinic acid (ALA).
Bartosová J; Hrkal Z
Comp Biochem Physiol C Toxicol Pharmacol; 2000 Jul; 126(3):245-52. PubMed ID: 11048674
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of lapatinib for enhancing 5-aminolevulinic acid-mediated protoporphyrin IX fluorescence and photodynamic therapy in human cancer cell lines with varied ABCG2 activities.
Howley R; Olsen J; Chen B
Photochem Photobiol; 2024 Mar; ():. PubMed ID: 38477138
[TBL] [Abstract][Full Text] [Related]
39. Corrigendum to "Protoporphyrin IX tracer fluorescence modulation for improved brain tumor cell lines visualization".
Piffaretti D; Burgio F; Thelen M; Kaelin-Lang A; Paganetti P; Reinert M; D'Angelo ML
J Photochem Photobiol B; 2020 Apr; 205():111828. PubMed ID: 32163836
[TBL] [Abstract][Full Text] [Related]
40. MEK reduces cancer-specific PpIX accumulation through the RSK-ABCB1 and HIF-1α-FECH axes.
Chelakkot VS; Liu K; Yoshioka E; Saha S; Xu D; Licursi M; Dorward A; Hirasawa K
Sci Rep; 2020 Dec; 10(1):22124. PubMed ID: 33335181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]